UNASSIGNED: 48 Background: With an increasing number of @entity1 receiving @entity5 therapies, evaluation of safe prescription practices, effective @entity1 education, and @entity137 monitoring of these agents is imperative. METHODS: Multi-disciplinary oncology practitioners at several @entity5 centres in Toronto, Canada were surveyed using a web-based platform, to evaluate their prescription practices, use of @entity1 education and symptom management tools, as well as their views on @entity1 adherence and @entity137 reporting. RESULTS: Of 170 respondents, 43% were nurses, 34% were pharmacists, and 23% were physicians. Seventy nine percent considered @entity1 education, medication adherence (76%), and @entity137 management (78%) as "very important" components of oral chemotherapy management. Prescription methods varied: 59% of respondents used written prescriptions, 39% computerized physician order entry (CPOE), and 0% pre-printed orders, >= 50% of the time. Clinicians felt that @entity1 report side effects from oral agents only "some of the time" (53%), and the most problematic @entity137 were @entity390 (61%) and @entity294 (61%). Practitioners perceived the most common reasons for @entity1 underreporting of side effects to be "fear of treatment interruption" (62%), and that " @entity137 are part of the treatment" (66%). Seventy three percent of those surveyed felt individual counseling, follow-up calls (69%), and updated medication information (57%) would improve @entity1 adherence and safety. CONCLUSIONS: A diverse group of surveyed oncology professionals expressed the importance of utilizing educational and @entity137 monitoring tools for @entity1 on @entity5 therapies, particularly as @entity1 are thought to under-report symptoms. Prescription practices are variable, and CPOE use should be improved. The results of this survey will also be compared to a @entity1 survey, to help develop better tools and policies to standardize practice, and improve @entity1 adherence and @entity137 management on @entity5 agents.

Health care practitioner prescribing patterns and perspectives on oral chemotherapy management: A survey of XXXX centers in Toronto, Canada.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity137 :: ('MESH:D064420', 'Disease') :: ['toxicity', 'toxicities'] @entity390 :: ('MESH:D009325', 'Disease') :: ['nausea'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'oral cancer'] @entity294 :: ('MESH:D003967', 'Disease') :: ['diarrhea']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
